Page last updated: 2024-12-05
2-chloro-1-propanol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6566 |
MeSH ID | M0150776 |
Synonyms (41)
Synonym |
---|
1-propanol, 2-chloro-, (s)- |
2-chloro-propan-1-ol |
1-hydroxy-2-chloropropane |
nsc-122672 |
2-chloropropanol |
2-chloro-1-propanol |
nsc122672 |
2-chloropropyl alcohol |
propylenechlorohydrin |
.beta.-chloropropyl alcohol |
78-89-7 |
wln: q1yg1 |
1-propanol, 2-chloro- |
nsc 122672 |
ccris 875 |
einecs 201-154-3 |
hsdb 5223 |
2-chloropropan-1-ol |
un2611 |
beta-chloropropyl alcohol |
FT-0652650 |
FT-0657974 |
A4232 |
AKOS006228269 |
unii-w3398732c7 |
w3398732c7 , |
propylene chlorohydrin [un2611] [poison] |
1-hydroxy-2-chloropropane [hsdb] |
propylene chlorohydrin [mi] |
.beta.-propylene chlorohydrin |
(r)-2-chloro-1-propanol |
DTXSID5052541 |
J-640389 |
un 2611 |
W-109278 |
propylenchlorhydrin |
Q15461615 |
SY240135 |
SB44668 |
SB44669 |
EN300-91182 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 41.52
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (41.52) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |